CORDLIFE GROUP LIMITED
Country of registration | Singapore |
Registration number | 200102883E |
Local SIC | |
Incorporation date | 2 May 2001 |
Company age | 25 years |
Official entity type | Public Company Limited By Shares |
No. of officers | 64 |
Contact
1 YISHUN INDUSTRIAL STREET 1, #06-01/09, A'POSH BIZHUB, Singapore 768160
This is the legal entity page of CORDLIFE GROUP LIMITED. To access company info, company size, news , key makers’ emails, visit the profile pages above.
- CORDLIFE SINGAPOREView MoreSingaporeListed on the Main Board of the Singapore Exchange (SGX), Cordlife Group Limited (Cordlife, and together with its subsidiaries, the Group) is presently a service provider of umbilical cord blood and cord lining banking. The first cord blood bank to be set up in Singapore (May 2001) and amongst the first in Asia, Cordlife Group Limited has more than 16 years of cord blood banking experience as well as a published track record of cord blood transplants. The Group currently owns and operates full processing and cryopreservation storage facilities across Asia, namely in Singapore, Hong Kong, India, Indonesia, Malaysia and the Philippines. Cordlife's processing and storage facilities in Singapore, Hong Kong and India are AABB accredited and by late 2015, the Singapore facility achieved accreditation from FACT-Netcord, placing the Group as one of the six international private cord blood banks that hold accreditations by two world-class standards. Besides being the first private cord blood bank in Southeast Asia to enjoy the dual-accreditation status, the Group also extends its products and services to families in the region through its associate in Thailand and sub-licensing partner in China. *Conditional accreditation status for Cordlife’s facility in Singapore
- CORDLIFE GROUP LIMITEDView MoreSingaporeCordlife is a leading player in the Asian cord blood banking industry, operating the largest network of cord blood banks across six key markets in Asia, including Singapore, Hong Kong, Indonesia, India, Malaysia, and the Philippines. With a strong presence in these markets, Cordlife is well positioned to capitalize on the growing demand for cord blood storage and stem cell banking services. Through its majority-owned subsidiary in Malaysia, Stemlife Berhad, Cordlife holds an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Additionally, Cordlife has expanded its reach into new markets such as Myanmar, Vietnam, Macau, Brunei, and Bangladesh.
Fiscal/Budgeting Period | October - December |
Auditor | KPMG LLP |
Revenue | 51m - 75m |
Financial period end date | 31 Dec 2021 |
Share Capital - Ordinary shares | SGD 99,325,263 |
Frequently Asked Questions (FAQ)
- What is the address of CORDLIFE GROUP LIMITED?
- Where is CORDLIFE GROUP LIMITED's headquarter?
- What is CORDLIFE GROUP LIMITED's contact number?
- What CORDLIFE GROUP LIMITED's spending power?
- Does CORDLIFE GROUP LIMITED have a presence in the domain it operates in?

